1 / 10

know-about-avn-treatment

It is a cell therapy that uses the patientu2019s own cells to cure avascular necrosis. This cell therapyu2019s main goal is to prevent young people from having hip replacements; it isnu2019t a cure-all, but it can offer long-term comfort.

regrow
Télécharger la présentation

know-about-avn-treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ossgrow: Learn In Detail About The Latest AVN Treatment Numerous individuals with chronic hip discomfort receive an avascular necrosis diagnosis. It is an illness that results in tiny breaches in the bone tissues, which progress and eventually lead to the bones collapsing as the tissues progressively degenerate from a lack of blood supply. Post-pandemic there has been a significant increase in AVN patients.

  2. The bone collapses due to blockage in the blood circulation to the hip joint. The usual causes of AVN include long-term steroid usage, alcohol use, smoking, trauma, genetic diseases, fatty deposits, and smoking. The age range of 30 to 50 is where it is more common. The symptoms of AVN are not always visible in the early stages, but as the illness worsens over a period of time leading to persistent pain and discomfort, ultimately causing restricted movement. The most recent alternative AVN treatment is called OSSGROW® Bone Cell Therapy and is offered by Regrow Biosciences.

  3. It is a cell therapy that uses the patient’s own cells to cure avascular necrosis. This cell therapy’s main goal is to prevent young people from having hip replacements; it isn’t a cure-all, but it can offer long-term comfort.

  4. What makes OSSGROW® Bone Cell Therapy a good choice? The primary objective of this treatment is to manage AVN and minimize the likelihood of hip replacement surgery, particularly in young patients. By creating new tissues, osteoblasts assist in mending the damage, which is how it works. This cell therapy has been shown to be an effective long-term alleviation option for AVN, enabling the patient to restore lost strength. It is a natural AVN treatment whose outcomes have been shown to be beneficial.

  5. What steps are involved? In order to grow the tissue, a sample of the patient’s bone marrow would be taken and sent to the lab for further culture. After this procedure, the cells are returned for implantation. After some time post-culture, the injured area begins to heal as new tissues begin to form.

  6. OSSGROW® Bone Cell Therapy brings many benefits such as: • Shorter hospital stay • No risk of foreign infections • Shorter recovery time • Regin mobility

  7. Is it too late for OSSGROW® treatment? Hip discomfort is frequently dismissed as ordinary joint pain without anybody questioning whether it may be something more. Another factor contributing to treatment delays is the fact that AVN symptoms don’t show up until much later in the disease’s progression, at which point surgery is the only remaining curative option. AlthoughOSSGROW® Bone Cell Therapyis not a substitute for surgery, it can be a good treatment choice in the early stages. It can assist someone in functioning as they did before AVN started interfering.

  8. What steps are taken after the treatment? The post-treatment phase is made simple by simple rehab for four to six weeks under the direction of an expert and qualified physiotherapist. Their assistance and attention enable you to restore your full vitality. Cell therapies are slowly becoming a popular treatment option. Apart from hip pain, it also helps in treating cartilage damage and urethral stricture. Investments in Regrow Biosciences have totaled about Rs 800 million, and further funding is anticipated for long-term growth. Approximately 3,000 patients can benefit from cell therapy treatments each year, and their mobility has improved noticeably. If you wish to know more about cell therapies get in touch with the experts.

  9. Thank You

More Related